|
|
|
|
|
SAFE PROJECTS & PARTNERS |
|
|
|
- In 2001-2002, SAFE helped lobby the government of Zimbabwe
for the right to import less expensive, generic antiretroviral
medications into the country so that treatment could be made
available to more people. The government granted this right
in 2003.
- In June and July of 2002, SAFE funded a public awareness radio campaign
featuring a popular Zimbabwe entertainer, Oliver Mtukudzi. The radio spots were
designed to educate the public about ways to avoid becoming infected with
HIV/AIDS. ( The radio spots can be heard on SAFE's home page )
- In 2003 - 2004, SAFE provided medicine for the first approved treatment protocol
of 20 AIDS mothers (and a few fathers) in Chitungwiza, Zimbabwe. These women had
already participated in a Mother-To-Child Transmission program which was
extremely successful – over 90% of the babies were born HIV negative. SAFE
partnered with the University of Zimbabwe (Zimbabwe AIDS Prevention Project),
Doctors Without Borders and Stanford University in providing the medicine to 20
of an initial group of 120 (later to grow to 300), so they will be able to live
and raise their newborn children. SAFE purchased shipments of
antiretroviral medicines from Cipla Ltd, a major generic pharmaceutical
manufacturer in India. Treatment in Chitungwiza began in June 2003 and the
recipients have responded very well to the medicine.
- In 2004, SAFE purchased and donated computer equipment to help
support a newly established Pediatric AIDS clinic in Harare,
Zimbabwe.
- In 2006, SAFE began lengthy negotiations with the Zimbabwe
Salvation Army and the government hospital in Karoi, Zimbabwe
(southeast of Victoria Falls) to provide anti-retroviral
medicines for residents of Karoi and residents of a
rural community called Nyamutora. A three-party cooperation
agreement was agreed upon in 2006 but medicine was not able
to be purchased and delivered until 2007. From 2007 through the
present, SAFE has provided various shipments of medicine for rural
villagers in Nyamutora. When hyperinflation made it too expensive for
villagers to take the bus to the hospital, SAFE provided fuel and the
Salvation Army provided a vehicle to transport them.
- In 2007,
SAFE initiated a pilot micro-credit project, together with
the Zambuko Trust, for members of the Batanai AIDS support group in Chitungwiza. The Batanai
support group consisted of people who received AIDS medicines from SAFE
and other donors beginning in 2003. SAFE believes the HIV/AIDS
tragedy in Zimbabwe requires a more holistic approach to deal
with the multi-faceted problems caused by HIV/AIDS and micro
loans to families living with HIV/AIDS is part of the solution. This tailor-made HIV/AIDS
micro-credit program was suspended in 2007 because of inflation in
Zimbabwe reaching over 2 million percent per annum
- In 2010, SAFE reacted to an outbreak of Cholera in Zimbabwe by
providing emergency water purification tablets to women and children
enabling them to purify thousands of liters of drinking water and help
thwart the spread of this deadly disease.
- In 2012, SAFE donated a variety of badly needed items (toothbrushes,
toothpaste, blankets and even a male pig!) to AIDS orphans in
Zimbabwe.
- In 2012, SAFE also began negotiating with its local partner to restart
the micro-credit program for the Batanai HIV/AIDS Support Group.
-
In the summer of 2012, SAFE agreed to help rebore the Nyamutora
village's well in order to provide drinking water to enable the
villagers to take their daily life-saving medicines.
- In
2013-2015, SAFE in partnership with the African Institute of Biomedical
Science & Technology (AiBST), arranged and funded a critical
research project for HIV/AIDS patients in Nyamutora Village (Karoi
District,Zimbabwe). Goals included further enhancing the treatment
of Nyamutora villagers (who SAFE has assisted since 2007) and creating
a low-cost treatment model which might be utilzed by other HIV/AIDS
patients elseware. Safe has been the sole sponsor of this research
aimed at demonstrating the feasability of integrating molecular
diagnostics in the treatment and monitoring of HIV/AIDS patients in
remote rural settings.
|
|
|